Metformin Had Potential to Increase Endocan Levels in STZ-Induced Diabetic Mice
Metformin Had Potential to Increase Endocan Levels in STZ-Induced Diabetic Mice
نویسندگان: هاله واعظ , المیرا زلالی , علیرضا گرجانی , حمیدرضا حیدری سورشجانی , رضا رهبرقاضی
کلمات کلیدی: -Diabetes
-Metformin
-Endocan
-p-AMPK/AMPK
نشریه: 27159 , 2 , 26 , 2020
| نویسنده ثبت کننده مقاله |
علیرضا گرجانی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
دانشکده داروسازی |
| کد مقاله |
72799 |
| عنوان فارسی مقاله |
Metformin Had Potential to Increase Endocan Levels in STZ-Induced Diabetic Mice |
| عنوان لاتین مقاله |
Metformin Had Potential to Increase Endocan Levels in STZ-Induced Diabetic Mice |
| ناشر |
6 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Background: Type 2 diabetes mellitus is a chronic metabolic disorder with prominent vascular
injuries. In this condition, the levels of multiple pro- and anti-angiogenic factors have been
shown to change. This study aimed to investigate the possible effect of metformin on proangiogenic factor, endocan levels, via the modulation of p-AMPK/AMPK axis in diabetic mice.
Methods: Mice were randomly assigned to one of 4 groups (n=6): Control (normal saline) and
the diabetic group was injected streptozotocin and two groups were given 50 and 100 mg/kg
metformin orally, once daily for two weeks after diabetes induction. Endocan protein levels were
detected in the liver and kidneys by ELISA and immunofluorescence analysis. Phosphorylation
of AMPK was assessed using western blotting. Histological examination was performed to follow
the metformin effect on Von Willebrand factor expression and diabetes-related pathologies.
Results: ELISA assay showed an elevated levels of endocan in the renal and hepatic tissues
of diabetic mice following treatment with metformin (p<0.05). Immunofluorescence and
immunohistochemistry examination of kidneys showed that the increase of endocan protein
coincided with the promotion of vWF factors in mice treated with metformin (p<0.05). We
did not find endocan factor in hepatic tissue of diabetic mice pre- and post-treatment with
metformin. Western blotting confirmed the phosphorylation of AMPK by metformin in
kidneys (p<0.05), but these changes did not reach statistically significant levels in hepatic tissues
(p>0.05).
Conclusion: Metformin could change the endocan levels during diabetic condition possibly by
the modulation of p-AMPK/AMPK axis |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| ps-26-133.pdf | 1399/04/15 | 9575861 | دانلود |